Showing posts with label statins. Show all posts
Showing posts with label statins. Show all posts

Saturday, September 22, 2018

Statins Were Only Beneficial In People Over 75 That Had Type 2 Diabetes!




"A large observational study has shown no benefit from statin therapy for primary prevention of atherosclerotic cardiovascular disease (CVD) or all-cause mortality in nondiabetic adults aged 75 and older. Atherosclerotic CVD was a composite of coronary heart disease (fatal and nonfatal angina, fatal and nonfatal myocardial infarction, or cardiac revascularization), and stroke (fatal and nonfatal ischemic stroke)." Read more...







Statin Benefits After 75 Limited to Patients With Diabetes.Megan Brooks. September 19, 2018. https://www.medscape.com/viewarticle/902217?src=soc_tw_180922_mscpedt_news_mdscp_statin%26faf%3D1

Saturday, August 25, 2018

There is a Higher Risk of Parkinson's With Statin Use!




"Thousands of people across the United States are diagnosed with Parkinson's disease every year. New research examines the effect of statins on the risk of developing this neurodegenerative disease. " Read more...





Statins may raise the risk of Parkinson's disease. Ana Sandoiu. June 15, 2017.

Sunday, April 26, 2015

Statins Raise Risk of Diabetes in Men By 44%!




"In the new study, during a 5.9-year follow-up, 625 men were diagnosed with Type 2 diabetes, determined by either an oral glucose tolerance test (OGTT), an HbA1c level of at least 6.5 percent, or the commencement of anti-diabetic medication. The results of the analysis revealed that men taking statins were at 44 percent higher risk of diabetes than men not taking statins."


Study Shows Increased Risk of Type 2 Diabetes for Statin Users. News Inferno. F.A. Kelley. April 22, 2015. http://www.newsinferno.com/study-shows-increased-risk-of-type-2-diabetes-for-statin-users/

Sunday, April 19, 2015

Even People on Statins Can Benefit From the Mediterranean Diet!




"The results of a ten-year study demonstrate the benefits of the Mediterranean Diet. According to the authors, the risk of cardiovascular disease (CVD) decreased by 29.3%. This decrease is independent of other variables such as smoking, gender, age, physical activity, etc. In addition, the study found that even patients on statins who had a higher risk of CVD could benefit from the Mediterranean diet intervention. "



Adherence to Mediterranean diet offers an additive protection over the use of statin therapy: results from the ATTICA study (2002-2012). Current vascular pharmacology (16 April 2015) by D. B. Panagiotakos, E. N. Georgousopoulou, G. A. Georgiopoulos, et al. http://www.citeulike.org/user/kimberlykramer2015/article/13586482

Thursday, March 26, 2015

Mediterranean Diet and CoQ10 Reduce the Overexpression of Oxidatve Stress!


A Mediterranean diet supplemented with CoQ10 provided enough antioxidant potential to allow for a reduction in the overexpression and activation of Nrf2 and other antioxidant genes against oxidative stress in the elderly. Oxidative stress often occurs after intake of a high lipid or high carb diet! Q10 is necessary for mitochondrial function and the natural process of aging decreases levels of q10 that may lead to disease. (Deichman)  "The principal aspects of the Mediterranean diet include proportionally high consumption of olive oil, legumes, unrefined cereals, fruits, and vegetables, moderate to high consumption of fish, moderate consumption of dairy products (mostly as cheese and yogurt), moderate wine consumption, and low consumption of meat and meat products. " (Wipedia)    


Postprandial antioxidant gene expression is modified by Mediterranean diet supplemented with coenzyme Q(10) in elderly men and women. Age (Dordrecht, Netherlands), Vol. 35, No. 1. (February 2013), pp. 159-170 by Elena M. Yubero-Serrano, Lorena Gonzalez-Guardia, Oriol Rangel-Zuñiga, et al.

Abstract: Postprandial oxidative stress is characterized by an increased susceptibility of the organism towards oxidative damage after consumption of a meal rich in lipids and/or carbohydrates. We have investigated whether the quality of dietary fat alters postprandial gene expression and protein levels involved in oxidative stress and whether the supplementation with coenzyme Q(10) (CoQ) improves this situation in an elderly population. Twenty participants were randomized to receive three isocaloric diets each for 4 weeks: Mediterranean diet supplemented with CoQ (Med + CoQ diet), Mediterranean diet (Med diet), saturated fatty acid-rich diet (SFA diet). After 12-h fast, volunteers consumed a breakfast with a fat composition similar to that consumed in each of the diets. Nrf2, p22(phox) and p47(phox), superoxide dismutase 1 and 2 (SOD1 and SOD2), glutathione peroxidase 1 (GPx1), thiorredoxin reductase (TrxR) gene expression and Kelch-like ECH associating protein 1 (Keap-1) and citoplasmic and nuclear Nrf2 protein levels were determined. Med and Med + CoQ diets induced lower Nrf2, p22(phox), p47(phox), SOD1, SOD2 and TrxR gene expression and higher cytoplasmic Nrf2 and Keap-1 protein levels compared to the SFA diet. Moreover, Med + CoQ diet produced lower postprandial Nrf2 gene expression and lower nuclear Nrf2 protein levels compared to the other diets and lower GPx1 gene expression than the SFA diet. Our results support the antioxidant effect of a Med diet and that exogenous CoQ supplementation has a protective effects against free radical overgeneration through the lowering of postprandial oxidative stress modifying the postprandial antioxidant protein levels and reducing the postprandial expression of antioxidant genes in peripheral blood mononuclear cells.

Coenzyme q10 and statin-induced mitochondrial dysfunction. The Ochsner journal, Vol. 10, No. 1. (2010), pp. 16-21 by Richard Deichmann, Carl Lavie, Samuel Andrews

Abstract: Coenzyme Q10 is an important factor in mitochondrial respiration. Primary and secondary deficiencies of coenzyme Q10 result in a number of neurologic and myopathic syndromes. Hydroxyl-methylglutaryl coenzyme A reductase inhibitors or statins interfere with the production of mevalonic acid, which is a precursor in the synthesis of coenzyme Q10. The statin medications routinely result in lower coenzyme Q10 levels in the serum. Some studies have also shown reduction of coenzyme Q10 in muscle tissue. Such coenzyme Q10 deficiency may be one mechanism for statin-induced myopathies. However, coenzyme Q10 supplements have not been shown to routinely improve muscle function. Additional research in this area is warranted and discussed in this review.